Bio-Rad Laboratories, Inc. (NYSE:BIO)
| CAPS Rating |
|
|---|---|
| Open | $103.07 |
| Previous Close | $103.45 |
| Daily Range | $102.05 - $103.33 |
| 52-Week Range | $84.02 - $126.98 |
| Market Cap | $2.89B |
| P/E Ratio | 14.30 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 39,754 |
| Average Daily Volume | 0 |
BIO
VS S&P 500 (SPY)
How do you think BIO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BIO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BIO News and Commentary
- Bio-Rad Laboratories Passes This Key Test – The Motley Fool
- Don't Get Too Worked Up Over Bio-Rad Laboratories' Earnings – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- Cepheid Shines With These 2 Metrics – The Motley Fool
- Don't Get Too Worked Up Over Techne's Latest Numbers – The Motley Fool
- Here's What Ariel's Great Investors Are Buying – The Motley Fool
- Cepheid Seems Solid With These 2 Metrics – The Motley Fool
- Why Bio-Rad Laboratories May Be About to Take Off – The Motley Fool
- OraSure Technologies Passes This Key Test – The Motley Fool
- Bio-Rad Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Here's How Harvard Bioscience May Be Failing You – The Motley Fool
- Bio-Rad Laboratories Earnings Preview – The Motley Fool
- Don't Get Too Worked Up Over Bio-Rad Laboratories' Earnings – The Motley Fool
- Immucor Shares Popped: What You Need to Know – The Motley Fool
- Can the Human Genetics Industry Survive the Courts? – The Motley Fool
- Here's What Ariel Capital Management Bought and Sold Last Quarter – The Motley Fool
- Does Agilent Technologies Deserve a Spot in Your Portfolio? – The Motley Fool
- Here's How Affymetrix Is Making You So Much Cash – The Motley Fool
- Here's How Affymetrix May Be Failing You – The Motley Fool
- What Shorts Might Be Watching at Affymetrix – The Motley Fool
RSS Headlines
Fool UK
